Serious adverse effects from the abortion pill are 22 times more frequent than previously thought, new research claims.

In a first-of-its-kind study, “The Abortion Pill Harms Women”, the Ethics and Public Policy Center (EPPC) says that, following a mifepristone abortion, 10.93 percent of women experience sepsis, infection, haemorrhaging, or another serious or life-threatening adverse event.

By contrast, the current US Federal Drug Administration (FDA) label says less than 0.5 percent experience severe adverse reactions.

The research authors have called on the FDA to revisit its previous research and amend its regulation of mifepristone.

“This study is the statistical equivalent of a category 5 hurricane hitting the prevailing narrative of the abortion industry, said lead author and EPPC President Ryan T. Anderson.

“It reveals, based on real-world data, the shocking number of women who suffer serious medical consequences because of the abortion pill. The Trump FDA should take immediate action to protect the safety of American women by reinstating the safety regulations that the Obama and Biden Administrations removed.”